Skip to main content

Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences

Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

ISTOCK, BOYMONSTERMany marine organisms have evolved to exist in some of the most extreme conditions on earth—high pressure, cold temperatures, hot thermal vents, or low light. As such, their genomes are a source of largely untapped information that could be useful for a wide variety of potential biomedical and industrial technologies. But who are the early prospectors mining these marine genetic resources (MGRs) and who stands to benefit from them? While the answer to the second question is not yet clear, a report in Science Advances today (June 6) suggests that, with 47 percent of all registered MGR patents, German chemical manufacturer BASF is by far the biggest fish in these speculative seas.

“This is an important paper as it shines a light on who owns genetic sequence patents in the international ocean . . . and illustrates how easy it is for resources in the deep ocean to be removed without notice,” Lisa Levin of the Scripps Institution of Oceanography who was not involved in the research writes in an email to The Scientist.

Anyone can go out there and get anything they want and do anything they want with it.—Robert Blasiak,
Stockholm University

“If marine genetic resources are patented on a first come, first served basis, without obligation to share benefits,” Levin continues, “then the majority of the countries of the world without the ability to sample, study and develop marine genetic resources will lose out ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo